My HPRA: Register

PALLADONE SR

8 Milligram Prolonged Release Capsules

Mundipharma Pharmaceuticals LimitedPA1688/007/009

Main Information

Trade NamePALLADONE SR
Active SubstancesHYDROMORPHONE HYDROCHLORIDE
Strength8 Milligram
Dosage FormProlonged Release Capsules
Licence HolderMundipharma Pharmaceuticals Limited
Licence NumberPA1688/007/009

Group Information

ATC CodeN02AA03 Natural opium alkaloids

Status

Authorised/WithdrawnAuthorised
Licence Issued12/08/2011
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 of the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.